Olaplex Holdings (OLPX) Valuation Check After Recent Share Price Momentum Rebuild

Olaplex Holdings, Inc.

Olaplex Holdings, Inc.

OLPX

0.00

Olaplex Holdings stock: event-driven snapshot

Olaplex Holdings (OLPX) has drawn fresh attention as investors weigh its current US$2.04 share price, its recent performance over the past 3 months, and an intrinsic discount figure alongside its latest reported financials.

While the latest US$2.04 share price has been steady in the very short term, the 90 day share price return of 64.52% alongside a 52.24% one year total shareholder return points to momentum rebuilding after a three year total shareholder return decline of 43.18%.

If this kind of share price reset has your attention, it could be a useful moment to widen your search and check out 19 top founder-led companies

With Olaplex trading at US$2.04, sitting close to analyst targets yet flagged with a 53.54% intrinsic discount, the real question is whether this reset signals a genuine buying opportunity or if the market already anticipates future growth.

Most Popular Narrative: 10.3% Overvalued

Against the last close at $2.04, the most followed narrative places fair value at $1.85, indicating a modest premium that investors are currently paying.

Olaplex's accelerated new product development, launching three innovations including entry into the fast-growing scalp health segment, positions the company to increase repeat purchases, capture incremental market share, and support revenue growth and margin expansion through proprietary, science-backed offerings.

This raises the question of what kind of revenue path and margin rebuild would justify that premium price tag. The narrative focuses on potential earnings power and valuation multiples.

Result: Fair Value of $1.85 (OVERVALUED)

However, the narrative leans heavily on a still evolving transformation, while specialty retail weakness and margin pressure could quickly challenge those fair value assumptions.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another View on Value

The popular narrative points to a fair value of US$1.85 and labels Olaplex as overvalued at US$2.04, yet Simply Wall St’s DCF model suggests the stock trades at a 53.5% discount to an estimated cash flow value of US$4.39. Which lens do you trust more for a long term view?

OLPX Discounted Cash Flow as at Jun 2026
OLPX Discounted Cash Flow as at Jun 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Olaplex Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals on value, risk, and potential upside, it makes sense to act promptly, weigh the data yourself, and then review the 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If Olaplex has you thinking more broadly about where to put fresh capital, now is a smart time to scan other shares that fit clear, disciplined criteria.

  • Spot potential bargains fast by checking the 47 high quality undervalued stocks, built around companies with quality fundamentals at marked down prices.
  • Prioritise resilience first by using the 63 resilient stocks with low risk scores to focus on businesses with steadier risk profiles.
  • Hunt for quality stories the crowd may have missed through the screener containing 20 high quality undiscovered gems, which highlight underfollowed stocks with solid underpinnings.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.